Hillhouse Leads $60M Series B Funding Round In Chinese IASO Biotherapeutics
March 23, 2020 — 15:51 CST
This Data Is Locked!
This area is available only to Subscribers.
IASO Biotherapeutics recently announced the completion of US$60 million in series B financing led by GL Ventures, a venture capital fund of Hillhouse Capital focusing... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals